Pharmacology of epigenetics in brain disorders
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Epigenetics is a rapidly growing field and holds great promise for a range of human diseases, including brain disorders such as Rett syndrome, anxiety and depressive disorders, schizophrenia, Alzheimer disease and Huntington disease. This review is concerned with the pharmacology of epigenetics to treat disorders of the epigenome whether induced developmentally or manifested/acquired later in life. In particular, we will focus on brain disorders and their treatment by drugs that modify the epigenome. While the use of DNA methyl transferase inhibitors and histone deacetylase inhibitors in in vitro and in vivo models have demonstrated improvements in disease‐related deficits, clinical trials in humans have been less promising. We will address recent advances in our understanding of the complexity of the epigenome with its many molecular players, and discuss evidence for a compromised epigenome in the context of an ageing or diseased brain. We will also draw on examples of species differences that may exist between humans and model systems, emphasizing the need for more robust pre‐clinical testing. Finally, we will discuss fundamental issues to be considered in study design when targeting the epigenome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 2×
“Elevated levels of homocysteine have been observed in AD patients, and are associated with folate and vitamin B12 deficiency (Seshadri et al., 2002; Morris, 2003).”
BackgroundHistone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · cited 2×
“, 1998; 2001), a HAT inhibitor that has been shown to interfere with the formation of amyloid plaques in AD rodent models (Lim et al., 2001; Ono et al., 2004; Yang et al., 2005; Ishrat et al., 2009).”
BackgroundActive Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138 · cited 2×
“…polycomb repressor complexes have been shown to associate with trimethylated histone H3 lysine 27 (H3K27Me3) to achieve transcriptional silencing (Hansen et al., 2008), while trithorax molecules associate with histone H3K4Me3 to activate genes (Francis and Kingston, 2001; Santos-Rosa et al., 2002).”
BackgroundSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“Bertram et al. (2007) performed meta-analysis on each known polymorphism for all known AD susceptibility genes based on available genotype data from at least three independent case-control samples.”
MethodDeficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“The second cleavage is performed by g-secretase which is a PSEN (either PSEN1 or PSEN2)dependent enzyme (Citron et al., 1997; De Strooper et al., 1998), and produces the APP intracellular domain (AICD, also known as an APP C-terminal fragment, APP-CT) and either a 3 kDa protein (p3, when in…”
BackgroundPhiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 1×
“Long-term treatment with VPA has been shown to have neuroprotective effects on neurones which may, at least in part be due to the more recently discovered role of VPA acting as an HDAC inhibitor (Gottlicher et al., 2001; Phiel et al., 2001).”
BackgroundHistone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542 · cited 1×
“Mutation or inhibition of one enzyme therefore results in the relative overactivity of the other (Xu et al., 2007).”
BackgroundLim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., Finch, C. E., St. Laurent III, G., Kenny, P. J., & Wahlestedt, C. (2008) · Nature Medicine · doi:10.1038/nm1784 · Cited by 1,416 · cited 2×
“Alterations in the expression of non-coding RNA (Faghihi et al., 2008) or of miR-106a and miR-520c (Patel et al.”
BackgroundSaxonov, S., Berg, P., & Brutlag, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510310103 · Cited by 1,401
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271 · cited 2×
“The second cleavage is performed by g-secretase which is a PSEN (either PSEN1 or PSEN2)dependent enzyme (Citron et al., 1997; De Strooper et al., 1998), and produces the APP intracellular domain (AICD, also known as an APP C-terminal fragment, APP-CT) and either a 3 kDa protein (p3, when in combination with a-secretas…”
BackgroundCurcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254 · cited 1×
“A recent study by Packer et al. (2008) demonstrated that several neuronal-specific mature miRNAs such as miR9 and miR9*, encoded upstream of REST binding sites, become dysregulated with disease progression in HD British Journal of Pharmacology (2010) 159 285–303 cortices compared to normal control.”
BackgroundHistone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228 · cited 1×
“They further demonstrated that HDAC inhibition prevented polyQ-induced toxicity and neurodegeneration (Steffan et al., 2001), and proposed a novel target for HD therapy.”
BackgroundRubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183 · cited 2×
“…al., 2008) or of miR-106a and miR-520c (Patel et al., 2008), or miRNAs belonging to the miR-20a family (Hebert et al., 2009) or miR-29a/b-1 cluster (Hebert et al., 2008) have been implicated in the regulation of APP and/or BACE1 expression (and their potential dysregulation in the context of AD).”
BackgroundKim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074 · cited 2×
“For example, HDAC inhibitors can reduce brain inflammation by inducing microglia apoptosis (Dragunow et al., 2006; Chen et al., 2007; Kim et al., 2007b), and also promote neurotrophin production by astrocytes (Chen et al., 2006; Wu et al., 2008c).”
BackgroundInvolvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis
Ikura, T., Ogryzko, V. V., Grigoriev, M., Groisman, R., Wang, J., Horikoshi, M., Scully, R., Qin, J., & Nakatani, Y. (2000) · Cell · doi:10.1016/s0092-8674(00)00051-9 · Cited by 1,029
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979 · cited 1×
“In HD brain, however, polyQ is unable to bind REST, resulting in its translocation to the nucleus, enabling it to mediate the dedifferentiation of cells of the neuronal phenotype (Zuccato et al., 2003).”
BackgroundCogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943 · cited 1×
“Altered miRNA expression in the cerebrospinal fluid of AD patients was found to correlate with altered patterns in AD brain and could be used in the future as a potential biomarker for diagnosis and/or for measuring treatment efficacy (Cogswell et al., 2008).”
BackgroundSequence Variants in SLITRK1 Are Associated with Tourette's Syndrome
Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rašin, M.-R., Gunel, M., et al. (2005) · Science · doi:10.1126/science.1116502 · Cited by 940 · cited 2×
“Evidence supporting this notion comes from aberrant miRNA-mediated regulation in Tourette’s syndrome (Abelson et al., 2005) and fragile X mental retardation (Jin et al., 2004).”
BackgroundVitamin B12, folic acid, and the nervous system
Reynolds, E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70598-1 · Cited by 860
Regional and cellular gene expression changes in human Huntington's disease brain
Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L. A., Hartog, C., Goldstein, D. R., Thu, D., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl013 · Cited by 804
Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis
Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., Jia, P., Assadzadeh, A., Flanagan, J., Schumacher, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.008 · Cited by 773 · cited 1×
“It has also been shown that SCZD patients have elevated homocysteine levels, and their corresponding promoters are hypermethylated (Abdolmaleky et al., 2005; Grayson et al., 2006; Huang and Akbarian, 2007; Mill et al., 2008).”
BackgroundFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 1×
“For example, HDAC 4, 5 and 7 (class II HDACs) all lack the ability to deacetylate histones on their own; they require interaction with HDAC3 (class I) to be active (Fischle et al., 2002).”
BackgroundElevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729 · cited 6×
“Wang et al. (2008b) found that miR-107 also targets the 3′UTR of BACE1 mRNA.”
BackgroundInfluentialPacker, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2390-08.2008 · Cited by 679 · cited 1×
“A recent study by Packer et al. (2008) demonstrated that several neuronal-specific mature miRNAs such as miR9 and miR9*, encoded upstream of REST binding sites, become dysregulated with disease progression in HD British Journal of Pharmacology (2010) 159 285–303 cortices compared to normal control.”
BackgroundPerkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574 · cited 1×
“Perkins et al. (2007) demonstrated that seven human miRNAs were significantly reduced in post-mortem prefrontal cortex of SCZD brain compared to normal controls.”
BackgroundIncreased expression of the amyloid precursor β‐secretase in Alzheimer's disease
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562
Reelin promoter hypermethylation in schizophrenia
Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503736102 · Cited by 553
Dicing and slicing: The core machinery of the RNA interference pathway
Hammond, S. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.079 · Cited by 545
Clark, R. F., Hutton, M., Fuldner, M., Froelich, S., Karran, E., Talbot, C., Crook, R., Lendon, C., Prihar, G., He, C., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-219 · Cited by 474
Post-transcriptional regulation of microRNA expression
Obernosterer, G., Leuschner, P. J. F., Alenius, M., & Martinez, J. (2006) · RNA · doi:10.1261/rna.2322506 · Cited by 474
Role of ampa receptor endocytosis in synaptic plasticity
Carroll, R. C., Beattie, E. C., von Zastrow, M., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072500 · Cited by 448 · cited 2×
“These genes have been shown to have important roles in the development of synaptic plasticity (Carroll et al., 2001) and the response of hippocampal neurones to glutamate stimulation (Spilker et al., 2002) respectively.”
BackgroundSethi, P., & Lukiw, W. J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.052 · Cited by 409 · cited 2×
“Another group recently showed that aberrant miRNA-mediated processing of mRNA can lead to abnormal levels of mRNA and consequent neuronal dysfunction in AD brain hippocampus post-mortem when compared to normal fetal and adult brain hippocampi (Lukiw, 2007; Sethi and Lukiw, 2009).”
BackgroundYasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358 · cited 1×
“The rationale for this study came from in vitro data where this combination of drugs was found to increase the expression of BDNF in cultured neurones (Yasuda et al., 2009).”
BackgroundHuang, H.-S., Matevossian, A., Whittle, C., Kim, S. Y., Schumacher, A., Baker, S. P., & Akbarian, S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3272-07.2007 · Cited by 352 · cited 2×
“…(H3K4Me3) to repressed (H3K27Me3) may also play a role in regulating the expression of another important GABAergic gene, glutamate decarboxylase 1 (GAD1) (Benson et al., 1994; Addington et al., 2005; Lundorf et al., 2005; Huang et al., 2007), which is also implicated in the pathogenesis of SCZD.”
BackgroundValproate Induces Replication-independent Active DNA Demethylation
Detich, N., Bovenzi, V., & Szyf, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303740200 · Cited by 345 · cited 1×
“VPA may also directly or indirectly induce DNA demethylation through HDAC inhibition (Detich et al., 2003; Dong et al., 2007).”
BackgroundEpigenetics of autism spectrum disorders
Schanen, N. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl213 · Cited by 341
Zuccato, C., Belyaev, N., Conforti, P., Ooi, L., Tartari, M., Papadimou, E., MacDonald, M., Fossale, E., Zeitlin, S., Buckley, N., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4278-06.2007 · Cited by 288
Vawter, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00377-2 · Cited by 275
Mellios, N., Huang, H.-S., Baker, S. P., Galdzicka, M., Ginns, E., & Akbarian, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.019 · Cited by 266 · cited 4×
“The pathoaetiology of SZCD may be linked to alterations in the expression and/or function of miRNAs.”
BackgroundInfluentialChen, P. S., Wang, C.-C., Bortner, C. D., Peng, G.-S., Wu, X., Pang, H., Lu, R.-B., Gean, P.-W., Chuang, D.-M., & Hong, J.-S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.053 · Cited by 262 · cited 1×
“For example, HDAC inhibitors can reduce brain inflammation by inducing microglia apoptosis (Dragunow et al., 2006; Chen et al., 2007; Kim et al., 2007b), and also promote neurotrophin production by astrocytes (Chen et al., 2006; Wu et al., 2008c).”
BackgroundIshrat, T., Hoda, M. N., Khan, M. B., Yousuf, S., Ahmad, M., Khan, M. M., Ahmad, A., & Islam, F. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.002 · Cited by 230 · cited 2×
“, 1998; 2001), a HAT inhibitor that has been shown to interfere with the formation of amyloid plaques in AD rodent models (Lim et al., 2001; Ono et al., 2004; Yang et al., 2005; Ishrat et al., 2009).”
BackgroundEndophenotypes in schizophrenia: A selective review
Allen, A. J., Griss, M. E., Folley, B. S., Hawkins, K. A., & Pearlson, G. D. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.016 · Cited by 210 · cited 2×
“Increasing evidence suggests that schizophrenia, instead of defining a discrete disease, may probably define a syndrome encompassing a complex group of diseases that may arise from common aetiology, but shared additional traits (Allen et al., 2009), based on the specific subset of genes dysregulated within a given gro…”
BackgroundCharacterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling
Guidotti, A., Dong, E., Kundakovic, M., Satta, R., Grayson, D. R., & Costa, E. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.010 · Cited by 130 · cited 1×
“For example, the co-administration of VPA with antipsychotics (clozapine, and sulpride) accelerates the demethylation of reelin and GAD67 genes (Dong et al., 2008; Guidotti et al., 2009).”
Background
Cited by
Bromodomains as therapeutic targets
Muller, S., Filippakopoulos, P., & Knapp, S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001992 · Cited by 442
Epigenetics of Stress-Related Psychiatric Disorders and Gene × Environment Interactions
Klengel, T., & Binder, E. B. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.036 · Cited by 353
“The bidirectional regulation of DNA methylation and other epigenetic marks leads to the question whether unidirectional drugs such as DNMT modulators or HDAC inhibitors can actually be used for the treatment of stress-elicited psychiatric disorders (Narayan and Dragunow, 2010; Szyf, 2009).”
BackgroundAn epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Methylation matters in child development: toward developmental behavioral epigenetics
van IJzendoorn, M. H., Bakermans-Kranenburg, M. J., & Ebstein, R. P. (2011) · Child Development Perspectives · doi:10.1111/j.1750-8606.2011.00202.x · Cited by 97
“…in children through psychosocial intervention (Bakermans-Kranenburg, van IJzendoorn, Pijlman, Mesman, & Child Development Perspectives, Volum Juffer, 2008; Cicchetti, Rogosch, & Toth, 2006; Dozier, Albus, Fisher, & Sepulveda, 2002) or pharmacological treatment (Narayan & Dragunow, 2010).”
Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry
Archer, T., & Blum, K. (2012) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000115 · Cited by 54
“, DNA methyl transferase inhibitors and histone deacetylase inhibitors) for disorder-related deficits emphasises the significance of epigenome targeting [47].”
Background
Metadata
- Authors
- Narayan, P., & Dragunow, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-01
- Volume
- 159
- Issue
- 2
- Pages
- 285-303
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2103555119
- Cited by
- 67
- References
- 50
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.